“WBENC certification is an important step for August Research, giving us enhanced
visibility in the pharmaceutical outsourcing marketplace. We are happy to have this
opportunity to showcase our high quality services supporting expedited and cost-effective
drug development efforts to the biopharmaceutical industry”, announced Chief Executive
Officer, Dana Leff Niedzielska.
WBENC’s national standard of certification implemented by the WPEO is a meticulous
process including an in-depth review of the business and site inspection. The certification
process is designed to confirm the business is at least 51% owned, operated and
controlled by a woman or women.
By including women-owned businesses among their suppliers, corporations and
government agencies demonstrate their commitment to fostering diversity and the
continued development of their supplier diversity programs.
To learn more about August Research, please visit www.augustresearch.com
About August Research:
August Research LLC was founded in 2012 to provide clinical trial services in Europe to
US and Global biopharmaceutical companies. The company focuses on Phase I-IV
clinical operations across Europe, managing clinical trials in a broad range of therapeutic
indications from Spain to Georgia. With a team of over 50 professionals across Europe,
August Research has the boots-on-the-ground to support clinical trials from regulatory
submission through enrollment, treatment and database lock. For more information visit:
Founded in 1997, WBENC is the nation’s leader in women’s business development and
the leading third-party certifier of businesses owned and operated by women, with more
than 13,000 certified Women’s Business Enterprises, 14 national Regional Partner
Organizations, and over 300 Corporate Members. More than 1,000 corporations
representing America’s most prestigious brands as well as many states, cities, and other
entities accept WBENC Certification. For more information, visit www.wbenc.org.